Literature DB >> 19020909

Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis.

C B E Chee1, T M S Barkham, K W Khinmar, S H Gan, Y T Wang.   

Abstract

The objective was to compare the quantitative T-cell responses measured by the commercial interferon-gamma (IFNgamma) release assays (IGRAs) in active and latent tuberculosis (TB) states. T-cell responses of culture-proven TB cases were compared with those of contacts with positive IGRA results and tuberculin skin tests >or= 15 mm. T-SPOT.TB results in 270 active TB cases and 183 community contacts showed the median spot-forming cells (SFCs) above negative control/2.5 x 10(5) peripheral blood mononuclear cells to be 27 (-1 to 203) vs 10 (-2 to 174) in response to ESAT-6 (p < 0.001); and 37 (0 to 293) vs 13 (0 to 225) to CFP-10 (p < 0.001). The median IFNgamma levels (antigen minus nil control) as measured by QuantiFERON-TB Gold In-tube in 270 cases and 142 contacts in congregate settings was 2.3 IU/ml (-0.58 to 31.44) vs 1.7 IU/ml (0.35 to 26.51, p = 0.98). Quantitative T-cell responses as measured by the T-SPOT.TB may indicate mycobacterial burden and disease activity, but cannot be used to discriminate active from latent TB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020909     DOI: 10.1007/s10096-008-0670-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Authors:  Katie Ewer; Jonathan Deeks; Lydia Alvarez; Gerry Bryant; Sue Waller; Peter Andersen; Philip Monk; Ajit Lalvani
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

2.  Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore.

Authors:  C B E Chee; M D Teleman; I C Boudville; S E Do; Y T Wang
Journal:  Int J Tuberc Lung Dis       Date:  2004-02       Impact factor: 2.373

3.  Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens.

Authors:  Cynthia B E Chee; Kyi W KhinMar; Suay H Gan; Timothy M S Barkham; Mariappan Pushparani; Yee T Wang
Journal:  Am J Respir Crit Care Med       Date:  2006-11-02       Impact factor: 21.405

4.  Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test.

Authors:  J-P Zellweger; A Zellweger; S Ansermet; B de Senarclens; P Wrighton-Smith
Journal:  Int J Tuberc Lung Dis       Date:  2005-11       Impact factor: 2.373

5.  Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment.

Authors:  M Pai; R Joshi; M Bandyopadhyay; P Narang; S Dogra; B Taksande; S Kalantri
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

6.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Authors:  Gerald H Mazurek; John Jereb; Phillip Lobue; Michael F Iademarco; Beverly Metchock; Andrew Vernon
Journal:  MMWR Recomm Rep       Date:  2005-12-16

Review 7.  New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.

Authors:  Madhukar Pai; Shriprakash Kalantri; Keertan Dheda
Journal:  Expert Rev Mol Diagn       Date:  2006-05       Impact factor: 5.225

8.  Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors:  Dick Menzies; Madhukar Pai; George Comstock
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

Review 9.  Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy.

Authors:  Ajit Lalvani
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

10.  Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases.

Authors:  Alexander M Aiken; Philip C Hill; Annette Fox; Keith P W J McAdam; Dolly Jackson-Sillah; Moses D Lugos; Simon A Donkor; Richard A Adegbola; Roger H Brookes
Journal:  BMC Infect Dis       Date:  2006-03-30       Impact factor: 3.090

View more
  20 in total

Review 1.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

Review 2.  Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery.

Authors:  Shajo Kunnath-Velayudhan; Maria Laura Gennaro
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study.

Authors:  Shiang-Fen Huang; Chung-Pin Li; Jia-Yih Feng; Yee Chao; Wei-Juin Su
Journal:  Gastric Cancer       Date:  2011-04-19       Impact factor: 7.370

4.  Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.

Authors:  Yoshihiro Kobashi; Hiroki Shimizu; Yoshihiro Ohue; Keiji Mouri; Yasushi Obase; Naoyuki Miyashita; Mikio Oka
Journal:  Lung       Date:  2010-04-27       Impact factor: 2.584

5.  Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model.

Authors:  Philana Ling Lin; Mark Rodgers; Le'kneitah Smith; Matthew Bigbee; Amy Myers; Carolyn Bigbee; Ion Chiosea; Saverio V Capuano; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

Review 6.  The Challenge of Inflammatory Bowel Disease Diagnosis in Asia.

Authors:  Yue Li; Jia-Ming Qian
Journal:  Inflamm Intest Dis       Date:  2016-08-19

7.  Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia.

Authors:  Mengistu Legesse; Gobena Ameni; Gezahegne Mamo; Girmay Medhin; Gunnar Bjune; Fekadu Abebe
Journal:  BMC Infect Dis       Date:  2010-12-17       Impact factor: 3.090

8.  Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells.

Authors:  Chanyi Lu; Jing Wu; Honghai Wang; Sen Wang; Ni Diao; Feifei Wang; Yan Gao; Jiazhen Chen; Lingyun Shao; Xinhua Weng; Ying Zhang; Wenhong Zhang
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

9.  Monocyte signal transduction receptors in active and latent tuberculosis.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Beata Janiszewska-Drobinska; Grzegorz Kielnierowski; Joanna Zawadzka; Magdalena Kowalewicz-Kulbat; Marek Fol; Piotr Szpakowski; Karolina Rudnicka; Magdalena Chmiela; Wieslawa Rudnicka
Journal:  Clin Dev Immunol       Date:  2013-01-20

10.  Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.

Authors:  Iukary Takenami; Brook Finkmoore; Almério Machado; Krisztina Emodi; Lee W Riley; Sérgio Arruda
Journal:  Pulm Med       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.